These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31094506)

  • 1. Accelerating the Throughput of Affinity Mass Spectrometry-Based Ligand Screening toward a G Protein-Coupled Receptor.
    Lu Y; Qin S; Zhang B; Dai A; Cai X; Ma M; Gao ZG; Yang D; Stevens RC; Jacobson KA; Wang MW; Shui W
    Anal Chem; 2019 Jul; 91(13):8162-8169. PubMed ID: 31094506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of affinity selection-mass spectrometry assays to purification and affinity-based screening of the chemokine receptor CXCR4.
    Whitehurst CE; Yao Z; Murphy D; Zhang M; Taremi S; Wojcik L; Strizki JM; Bracken JD; Cheng CC; Yang X; Shipps GW; Ziebell M; Nickbarg E
    Comb Chem High Throughput Screen; 2012 Jul; 15(6):473-85. PubMed ID: 22651846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple ligand detection and affinity measurement by ultrafiltration and mass spectrometry analysis applied to fragment mixture screening.
    Qin S; Ren Y; Fu X; Shen J; Chen X; Wang Q; Bi X; Liu W; Li L; Liang G; Yang C; Shui W
    Anal Chim Acta; 2015 Jul; 886():98-106. PubMed ID: 26320641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity selection-mass spectrometry and its emerging application to the high throughput screening of G protein-coupled receptors.
    Whitehurst CE; Annis DA
    Comb Chem High Throughput Screen; 2008 Jul; 11(6):427-38. PubMed ID: 18673271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.
    Massink A; Holzheimer M; Hölscher A; Louvel J; Guo D; Spijksma G; Hankemeier T; IJzerman AP
    Purinergic Signal; 2015 Dec; 11(4):581-94. PubMed ID: 26482925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.
    Morfa CJ; Bassoni D; Szabo A; McAnally D; Sharir H; Hood BL; Vasile S; Wehrman T; Lamerdin J; Smith LH
    Assay Drug Dev Technol; 2018 Oct; 16(7):384-396. PubMed ID: 30251873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein-Ligand Interactions at High Throughput.
    Simon RP; Winter M; Kleiner C; Wehrle L; Karnath M; Ries R; Zeeb M; Schnapp G; Fiegen D; Häbe TT; Runge F; Bretschneider T; Luippold AH; Bischoff D; Reindl W; Büttner FH
    SLAS Discov; 2021 Jan; 26(1):44-57. PubMed ID: 33073664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Affinity-Based Probe for the Human Adenosine A
    Yang X; Michiels TJM; de Jong C; Soethoudt M; Dekker N; Gordon E; van der Stelt M; Heitman LH; van der Es D; IJzerman AP
    J Med Chem; 2018 Sep; 61(17):7892-7901. PubMed ID: 30080404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.
    Muchiri RN; van Breemen RB
    J Mass Spectrom; 2021; 56(5):e4647. PubMed ID: 32955158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay.
    Zeghal M; Laroche G; Giguère PM
    J Vis Exp; 2020 Mar; (157):. PubMed ID: 32225148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Magnetic Microbead Affinity Selection Screen (MagMASS) Using Mass Spectrometry for Ligands to the Retinoid X Receptor-α.
    Rush MD; Walker EM; Prehna G; Burton T; van Breemen RB
    J Am Soc Mass Spectrom; 2017 Mar; 28(3):479-485. PubMed ID: 27966173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
    Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
    J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a High-Throughput Affinity Mass Spectrometry (AMS) Platform Using Laser Diode Thermal Desorption Ionization Coupled to Mass Spectrometry (LDTD-MS).
    Sahasrabuddhe A; Oakley D; Chen K; McCarter JD
    SLAS Discov; 2021 Feb; 26(2):230-241. PubMed ID: 33334237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of Affinity Selection-Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway.
    Kutilek VD; Andrews CL; Richards MP; Xu Z; Sun T; Chen Y; Hashke A; Smotrov N; Fernandez R; Nickbarg EB; Chamberlin C; Sauvagnat B; Curran PJ; Boinay R; Saradjian P; Allen SJ; Byrne N; Elsen NL; Ford RE; Hall DL; Kornienko M; Rickert KW; Sharma S; Shipman JM; Lumb KJ; Coleman K; Dandliker PJ; Kariv I; Beutel B
    J Biomol Screen; 2016 Jul; 21(6):608-19. PubMed ID: 26969322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening.
    Qin S; Meng M; Yang D; Bai W; Lu Y; Peng Y; Song G; Wu Y; Zhou Q; Zhao S; Huang X; McCorvy JD; Cai X; Dai A; Roth BL; Hanson MA; Liu ZJ; Wang MW; Stevens RC; Shui W
    Chem Sci; 2018 Mar; 9(12):3192-3199. PubMed ID: 29732102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method for quantitative protein-ligand affinity measurements in compound mixtures.
    Annis DA; Shipps GW; Deng Y; Popovici-Müller J; Siddiqui MA; Curran PJ; Gowen M; Windsor WT
    Anal Chem; 2007 Jun; 79(12):4538-42. PubMed ID: 17500537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
    Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
    ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery.
    Kapolka NJ; Taghon GJ; Rowe JB; Morgan WM; Enten JF; Lambert NA; Isom DG
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13117-13126. PubMed ID: 32434907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.